Evidence map›Paper›PMID 21775610›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2011

Dopamine acts as a partial agonist for α2A adrenoceptor in melanin-concentrating hormone neurons.

Christian O Alberto, Robert B Trask, Michiru Hirasawa

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Sleep Deprivation Distinctly Alters Glutamate Transporter 1 Apposition and Excitatory Transmission to Orexin and MCH Neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Christian O AlbertoDivision of Biomedical Sciences, Faculty of Medicine, Memorial University, St. John's, Newfoundland and Labrador A1B 3V6, Canada.
Robert B Trask
Michiru Hirasawa
Memorial University of Newfoundland · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

Melanin-concentrating hormone (MCH) is a hypothalamic neuropeptide that promotes positive energy balance and anxiety. Since dopamine (DA) is also closely implicated in these functions, the present study investigated the effect of DA on MCH neurons. Using whole-cell patch-clamp recordings in rat brain slices, we found that DA hyperpolarizes MCH neurons by activating G-protein-activated inwardly rectifying K(+) (GIRK) channels. Pharmacological study indicated that the effect was mediated by α2A adrenoceptors, not DA receptors. DA-induced outward current was also observed in the presence of tetrodotoxin or the dopamine β-hydroxylase inhibitor fusaric acid, suggesting that DA directly binds to α2A receptors on MCH neurons, rather than acting presynaptically or being transformed into norepinephrine (NE) in the slice preparation. The effects of NE and DA were concentration-dependent with EC(50) of 5.9 and 23.7 μm, respectively, and a maximal effect of 106.6 and 57.2 pA, respectively, suggesting that DA functions as a partial agonist. Prolonged (5 min) activation of α2A receptors by either DA or NE attenuated the subsequent response to DA or NE, while 5 s applications were not sufficient to induce desensitization. Therefore, a history of α2A receptor activation by DA or NE can have a lasting inhibitory effect on the catecholaminergic transmission to MCH neurons. Our study suggests that α2A receptors expressed by MCH neurons may be one of the pathways by which DA and NE can interact and modulate mood and energy homeostasis, and this cross talk may have functional implications in mood disorders and obesity.

Indexed as

Action PotentialsAdrenergic alpha-2 Receptor AgonistsAdrenergic alpha-2 Receptor AntagonistsAnalysis of VarianceAnimalsBee VenomsCarbolinesDopamineDopamine AgonistsDopamine AntagonistsDose-Response Relationship, DrugDrug InteractionsExcitatory Amino Acid AntagonistsHypothalamusIn Vitro TechniquesMelaninsAdrenergic alpha-2 Receptor AgonistsAdrenergic alpha-2 Receptor AntagonistsBee VenomsCarbolinesDopamineDopamine AgonistsDopamine AntagonistsExcitatory Amino Acid AntagonistsMelaninsPotassium Channel Blockerstertiapintryptoline

Identifiers

PMID21775610
PMCPMC6622637
OpenAlexW2070825252

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.